These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 23843959)
1. The proton pump inhibitor lansoprazole improves the skeletal phenotype in dystrophin deficient mdx mice. Sali A; Many GM; Gordish-Dressman H; van der Meulen JH; Phadke A; Spurney CF; Cnaan A; Hoffman EP; Nagaraju K PLoS One; 2013; 8(7):e66617. PubMed ID: 23843959 [TBL] [Abstract][Full Text] [Related]
2. Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophy. Janssen PM; Murray JD; Schill KE; Rastogi N; Schultz EJ; Tran T; Raman SV; Rafael-Fortney JA PLoS One; 2014; 9(2):e88360. PubMed ID: 24551095 [TBL] [Abstract][Full Text] [Related]
3. Nutraceutical and pharmaceutical cocktails did not improve muscle function or reduce histological damage in D2-mdx mice. Spaulding HR; Quindry T; Hammer K; Quindry JC; Selsby JT J Appl Physiol (1985); 2019 Oct; 127(4):1058-1066. PubMed ID: 31295065 [TBL] [Abstract][Full Text] [Related]
4. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle. Lindsay A; Larson AA; Verma M; Ervasti JM; Lowe DA J Appl Physiol (1985); 2019 Feb; 126(2):363-375. PubMed ID: 30571283 [TBL] [Abstract][Full Text] [Related]
5. Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors. Cai B; Spencer MJ; Nakamura G; Tseng-Ong L; Tidball JG Am J Pathol; 2000 May; 156(5):1789-96. PubMed ID: 10793090 [TBL] [Abstract][Full Text] [Related]
6. Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy. Capogrosso RF; Mantuano P; Uaesoontrachoon K; Cozzoli A; Giustino A; Dow T; Srinivassane S; Filipovic M; Bell C; Vandermeulen J; Massari AM; De Bellis M; Conte E; Pierno S; Camerino GM; Liantonio A; Nagaraju K; De Luca A FASEB J; 2018 Feb; 32(2):1025-1043. PubMed ID: 29097503 [TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-treated mice are an inappropriate positive control for long-term preclinical studies in the mdx mouse. Sali A; Guerron AD; Gordish-Dressman H; Spurney CF; Iantorno M; Hoffman EP; Nagaraju K PLoS One; 2012; 7(4):e34204. PubMed ID: 22509280 [TBL] [Abstract][Full Text] [Related]
9. Loss of dystrophin expression in skeletal muscle is associated with senescence of macrophages and endothelial cells. Young LV; Morrison W; Campbell C; Moore EC; Arsenault MG; Dial AG; Ng S; Bellissimo CA; Perry CGR; Ljubicic V; Johnston AP Am J Physiol Cell Physiol; 2021 Jul; 321(1):C94-C103. PubMed ID: 33979211 [TBL] [Abstract][Full Text] [Related]
10. Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle. De Luca A; Nico B; Rolland JF; Cozzoli A; Burdi R; Mangieri D; Giannuzzi V; Liantonio A; Cippone V; De Bellis M; Nicchia GP; Camerino GM; Frigeri A; Svelto M; Camerino DC Neurobiol Dis; 2008 Nov; 32(2):243-53. PubMed ID: 18694830 [TBL] [Abstract][Full Text] [Related]
11. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function. Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760 [TBL] [Abstract][Full Text] [Related]
12. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351 [TBL] [Abstract][Full Text] [Related]
13. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice. Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy. Cozzoli A; Rolland JF; Capogrosso RF; Sblendorio VT; Longo V; Simonetti S; Nico B; De Luca A Neuropathol Appl Neurobiol; 2011 Apr; 37(3):243-56. PubMed ID: 20618838 [TBL] [Abstract][Full Text] [Related]